Loading...
menu
Search
Features
Markets
News
Resources
Pricing
Home
ETF
TERN
TERN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
Latest TERN ETF News Today | Earnings, Events & Price Alerts
TERN News
ORBIMED Reduces Stake in Terns Pharmaceuticals
Feb 20 2026
Fool
ORBIMED Reduces Stake in Terns Pharmaceuticals
Feb 20 2026
NASDAQ.COM
First Turn Management Acquires Stake in Terns Pharmaceuticals
Feb 17 2026
Fool
Viking Therapeutics CEO Highlights Broad Strategic Interest in Weight-Loss Drug Deals, Shares Surge 17%
Jan 14 2026
stocktwits
CleanSpark Inc. (CLSK) Jumps 14.13% Ahead of Mining Report for December 2025
Jan 03 2026
Yahoo Finance
Terns Pharmaceuticals Grants 312,000 Stock Options to New Employees
Jan 02 2026
Globenewswire
Palvella Therapeutics Stock Soars to $114.69 Following Pipeline Developments
Dec 31 2025
NASDAQ.COM
Terns Pharmaceuticals (TERN) Sees Price Target Raised by 75.91% to 54.63
Dec 21 2025
NASDAQ.COM
Cramer's Lighting Round: Exercise Caution with Lumen Technologies
Dec 16 2025
CNBC
Terns Pharmaceuticals Closes $747.5 Million Public Offering of 18.69 Million Shares
Dec 11 2025
Globenewswire
Terns Pharmaceuticals Prices Upsized Offering of 16.25 Million Shares at $40 Each, Raising $650 Million
Dec 10 2025
Globenewswire
Cancer Research Boosts Confidence in These Small Biotech Companies
Dec 09 2025
Barron's
Broadcom Set for Approximately 10% Surge? Check Out 10 Leading Analyst Predictions for Tuesday
Dec 09 2025
Benzinga
Small Biotech Terns Targets Novartis' Leading Leukemia Drug
Dec 09 2025
Benzinga
Terns Pharmaceuticals Proposes $400 Million Public Offering to Fund R&D
Dec 09 2025
Globenewswire
Terns Pharmaceuticals Initiates $400 Million Public Offering
Dec 09 2025
NASDAQ.COM
Show More News
